Výsledky vyhledávání - "Suárez-Lombraña A"

Akademický článek

Clinical and subclinical arteriosclerotic disease in octagenarians with hip fracture. A case–control study

Autor: Capdevila-Reniu, Aina, Navarro-López, Margarita, Sierra-Benito, Cristina, Sapena, Victor, Suárez-Lombraña, Ana, Camafort-Babkowski, Miguel, López-Soto, Alfonso

Publikováno v: In Medicina Clinica 15 November 2024 163(9):431-435

Zobrazit plný text záznamu

Clinical and Subclinical Arteriosclerotic Disease in Octagenarians With Hip Fracture. A Case – Control Study

Autor: Aina Capdevila-Reniu, Margarita Navarro-López, Cristina Sierra-Benito, Victor Sapena, Ana Suárez-Lombraña, Bryan David Solari, Marta Arroyo, Miguel Camafort-Babkowski, Alfonso López-Soto

Background: Osteoporosis and cardiovascular diseases share risk factors and pathophysiological mechanisms. Hip fracture and cardiovascular diseases are very common in older people. Objectives: Evaluate clinical and subclinical arteriosclerotic diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::be1548709bf65952d367a325865c3829
https://doi.org/10.21203/rs.3.rs-2085949/v1

Zobrazit plný text záznamu

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19

Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine, Vol 10, Iss 2642, p 2642 (2021)
Journal of clinical medicine
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Journal of Clinical Medicine
Volume 10
Issue 12
Journal of Clinical Medicine 10(12), 2642 (2021)
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba
r-FISABIO. Repositorio Institucional de Producción Científica
Helvia. Repositorio Institucional de la Universidad de Córdoba

Our main aim was to describe the effect on the severity of ACEI (angiotensin-converting enzyme inhibitor) and ARB (angiotensin II receptor blocker) during COVID-19 hospitalization. A retrospective, observational, multicenter study evaluating hospital

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1e064a11c5c931a2fed019fb8c59d95
http://hdl.handle.net/2445/179215

Zobrazit plný text záznamu

Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain

Publikováno v: Hypertension (Dallas, Tex. : 1979)
Hypertension
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
HYPERTENSION
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Dipòsit Digital de la UB
Universidad de Barcelona
r-FISABIO. Repositorio Institucional de Producción Científica

Older age and cardiovascular comorbidities are well-known risk factors for all-cause mortality in patients with coronavirus disease 2019 (COVID-19). Hypertension and age are the 2 principal determinants of arterial stiffness (AS). This study aimed to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25327f3e79f905739232cbe15dd0c1c2
http://hdl.handle.net/2445/177711

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19.

Autor: Roy-Vallejo E; Department of Internal Medicine, La Princesa University Hospital, Healthcare Research Institute-La Princesa Biomedical Research Foundation, 28006 Madrid, Spain., Sánchez Purificación A; Department of Internal Medicine, La Paz University Hospital, Hospital La Paz Institute for Health Research (IdiPAZ), Autonomous University of Madrid, 28046 Madrid, Spain., Torres Peña JD; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, 14004 Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Institute of Health, 28029 Madrid, Spain., Sánchez Moreno B; Department of Internal Medicine, La Princesa University Hospital, Healthcare Research Institute-La Princesa Biomedical Research Foundation, 28006 Madrid, Spain., Arnalich F; Department of Internal Medicine, La Paz University Hospital, Hospital La Paz Institute for Health Research (IdiPAZ), Autonomous University of Madrid, 28046 Madrid, Spain., García Blanco MJ; Department of Internal Medicine, La Princesa University Hospital, Healthcare Research Institute-La Princesa Biomedical Research Foundation, 28006 Madrid, Spain., López Miranda J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, 14004 Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Institute of Health, 28029 Madrid, Spain., Romero-Cabrera JL; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, 14004 Córdoba, Spain.; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Institute of Health, 28029 Madrid, Spain., Herrero Gil CR; Department of Internal Medicine, La Paz University Hospital, Hospital La Paz Institute for Health Research (IdiPAZ), Autonomous University of Madrid, 28046 Madrid, Spain., Bascunana J; Internal Medicine Department, 12 de Octubre University Hospital, 28041 Madrid, Spain., Rubio-Rivas M; Internal Medicine Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, 08907 Barcelona, Spain., Pintos Otero S; Internal Medicine Department, Zamora Hospital Complex, 49022 Zamora, Spain., Martínez Sempere V; Internal Medicine Department, San Juan de Alicante University Hospital, 03550 San Juan de Alicante, Spain., Ballano Rodríguez-Solís J; Internal Medicine Department, Henares Hospital, 28822 Coslada, Spain., Gil Sánchez R; Internal Medicine Department, La Fe University Hospital, 46026 Valencia, Spain., Luque Del Pino J; Internal Medicine Department, Costa del Sol Hospital, 29603 Marbella, Spain., González Noya A; Internal Medicine Department, Ourense University Hospital Complex, 32005 Ourense, Spain., Navas-Alcántara MS; Internal Medicine Department, Infanta Margarita Hospital, 14940 Cabra, Spain., Cortés Rodríguez B; Internal Medicine Department, Alto Guadalquivir Hospital, 23740 Andújar, Spain., Alcalá JN; Internal Medicine Department, Pozoblanco Hospital, 14400 Pozoblanco, Spain., Suárez-Lombraña A; Internal Medicine Department, Platón Hospital, 08006 Barcelona, Spain., Andrés Soler J; Internal Medicine Department, Castellón University General Hospital, 12004 Castellón de la Plana, Spain., Gómez-Huelgas R; Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), 29010 Málaga, Spain., Casas-Rojo JM; Internal Medicine Department, Infanta Cristina University Hospital, 28981 Parla, Spain., Millán Núñez-Cortés J; Internal Medicine Department, Gregorio Marañón University Hospital, 28007 Madrid, Spain., On Behalf Of The Semi-Covid-Network

Publikováno v: Journal of clinical medicine [J Clin Med] 2021 Jun 15; Vol. 10 (12). Date of Electronic Publication: 2021 Jun 15.

Zobrazit plný text záznamu

Akademický článek

Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain.

Autor: Rodilla E; From the Internal Medicine Department, Hypertension and Vascular Risk Unit, Sagunto University Hospital, Sagunto (Valencia), Spain (E.R., X.C., S.C., M.C.S.).; Department of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain (E.R., X.C., S.C., M.C.S.)., López-Carmona MD; Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Spain (M.D.L.-C., L.C.-P., R.G.H.)., Cortes X; From the Internal Medicine Department, Hypertension and Vascular Risk Unit, Sagunto University Hospital, Sagunto (Valencia), Spain (E.R., X.C., S.C., M.C.S.).; Department of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain (E.R., X.C., S.C., M.C.S.)., Cobos-Palacios L; Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Spain (M.D.L.-C., L.C.-P., R.G.H.)., Canales S; From the Internal Medicine Department, Hypertension and Vascular Risk Unit, Sagunto University Hospital, Sagunto (Valencia), Spain (E.R., X.C., S.C., M.C.S.).; Department of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain (E.R., X.C., S.C., M.C.S.)., Sáez MC; From the Internal Medicine Department, Hypertension and Vascular Risk Unit, Sagunto University Hospital, Sagunto (Valencia), Spain (E.R., X.C., S.C., M.C.S.).; Department of Medicine, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain (E.R., X.C., S.C., M.C.S.)., Campos Escudero S; Internal Medicine Department, 12 de Octubre University Hospital, Madrid, Spain (S.C.E.)., Rubio-Rivas M; Internal Medicine Department, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat (Barcelona), Spain (M.R.-R.)., Díez Manglano J; Internal Medicine Department, Royo Villanova Hospital, Zaragoza, Spain (J.D.M.)., Freire Castro SJ; Internal Medicine Department, A Coruña University Hospital, Spain (S.J.F.C.)., Vázquez Piqueras N; Internal Medicine Department, Consorci Sanitari Integral, Moisès Broggi Hospital Sant Joan Despí (Barcelona), Spain (N.V.P.)., Mateo Sanchis E; Internal Medicine Department, Dr. Peset University Hospital, Valencia, Spain (E.M.S.)., Pesqueira Fontan PM; Internal Medicine Department, Santiago Clinical Hospital, Santiago de Compostela (A Coruña), Spain (P.M.P.F.)., Magallanes Gamboa JO; Internal Medicine Department, Nuestra Señora del Prado Hospital, Talavera de la Reina (Toledo), Spain (J.O.M.G.)., González García A; Internal Medicine Department, Ramón y Cajal University Hospital, Madrid, Spain (A.G.G.).; Internal Medicine Department, Defensa General Hospital, Zaragoza, Spain (A.G.G.)., Madrid Romero V; Internal Medicine Department, Zamora Hospital Complex, Spain (V.M.R.)., Tamargo Chamorro L; Internal Medicine Department, Cabueñes Hospital, Gijón (Asturias), Spain (L.T.C.)., González Moraleja J; Internal Medicine Department, Virgen de la Salud Hospital, Toledo, Spain (J.G.M.)., Villanueva Martínez J; Internal Medicine Department, Infanta Cristina University Hospital, Parla (Madrid), Spain (J.V.M.)., González Noya A; Internal Medicine Department, Ourense University Hospital Complex, Ourense, Spain (A.G.N.)., Suárez-Lombraña A; Internal Medicine Department, Platón Hospital, Barcelona, Spain (A.S.-L.)., Gracia Gutiérrez A; Internal Medicine Department, Ramón y Cajal University Hospital, Madrid, Spain (A.G.G.).; Internal Medicine Department, Defensa General Hospital, Zaragoza, Spain (A.G.G.)., López Reboiro ML; Internal Medicine Department, Monforte de Lemos Hospital, Spain (M.L.L.R.)., Ramos Rincón JM; Department of Clinical Medicine, Miguel Hernandez University of Elche, Alicante, Spain (J.M.R.R.)., Gómez Huelgas R; Internal Medicine Department, Regional University Hospital of Málaga, Biomedical Research Institute of Málaga (IBIMA), University of Málaga (UMA), Spain (M.D.L.-C., L.C.-P., R.G.H.).

Publikováno v: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2021 Mar 03; Vol. 77 (3), pp. 856-867. Date of Electronic Publication: 2020 Dec 30.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání